Cognitive functioning and cerebrospinal fluid concentrations of neuropeptides for patients with good neurological outcomes after aneurysmal subarachnoid hemorrhage.
Uski. T K TK; Lilja. A A; Säveland. H H; Ekman. R R; Sonesson. B B; Brandt. L L
Key Findings
- Patients with post‑SAH cognitive deficits had elevated CSF levels of beta‑endorphin, CRF, and DSIP compared to those with normal cognition.
- No relationship was found between CSF levels of vasopressin or neuropeptide Y and cognitive performance.
- The study involved a small sample (17 patients) and measured peptides 3–6 months after surgery.
Practical Outcomes
- For biohackers, this research does not provide a clear, actionable protocol for using DSIP or related peptides to boost cognition or recovery. It suggests that higher DSIP may be a marker of brain stress after injury, but there is no evidence that supplementing DSIP will improve brain function in healthy or non‑injured individuals.
Summary
In people who survived a brain bleed (aneurysmal subarachnoid hemorrhage) and seemed otherwise healthy, those who still had memory or thinking problems had higher levels of certain brain chemicals—beta‑endorphin, corticotropin‑releasing factor, and delta‑sleep‑inducing peptide (DSIP)—in their spinal fluid. The study does not show that taking these peptides will help, only that they are associated with lingering cognitive issues after a serious brain injury.
Abstract
Many patients exhibit cognitive disturbances after aneurysmal subarachnoid hemorrhage (SAH). Structural and functional neuroimaging has failed to demonstrate any correlation with these complaints. This study was performed to investigate whether neuropeptide concentrations in cerebrospinal fluid could be related to cognitive disturbances after SAH. Lumbar cerebrospinal fluid was obtained, 3 to 6 months after surgery, from 17 patients who experienced good outcomes after aneurysmal SAH. The samples were analyzed for various neuropeptides using radioimmunoassays, and the peptide concentrations were evaluated in relation to scores on standardized neuropsychological tests. The neuropsychological test results were normal for eight individuals, whereas the remaining nine patients exhibited various degrees of cognitive impairment. There was no correlation between the concentrations of arginine vasopressin or neuropeptide Y and test performance. However, significant correlations between cognitive impairment and elevated levels of beta-endorphins (P = 0.02), corticotropin-releasing factor (P = 0.004), and delta sleep-inducing peptide (P = 0.045) were noted. Patients with cognitive impairments after aneurysmal SAH exhibited higher cerebrospinal fluid concentrations of endorphins, corticotropin-releasing factor, and delta sleep-inducing peptide than did those with normal capacity. This is probably attributable to diffuse derangement of transmitter release in the brain, resulting from the insult or ensuing complications, although a secondary increase in corticotropin-releasing factor concentrations caused by increased stress during the testing because of reduced cognitive capacity cannot be excluded.
Study Information
pubmed
2000
2000-10-01T00:00:00.000Z
10.1097/00006123-200010000-00002
17
31